Haleon Turns to Weight-Loss Drug Users for its Next U.S. Growth Opportunity
Haleon plc (NYSE:HLN) is finding a new growth opportunity in the expanding U.S. population using GLP-1 weight-loss drugs such as Wegovy and Zepbound.
Haleon Plc (HLN)
Market is closed
News See All
10 Best Up and Coming Stocks to Invest In Right Now
In this article, we will discuss the 10 Best Up and Coming Stocks to Invest In Right Now.
Is Haleon plc (HLN) Stock Still a Growth Opportunity After Analyst Downgrade?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Haleon plc (NYSE:HLN) is among the best healthcare stocks.
10 Best Healthcare Stocks to Buy According to Wall Street Analysts
In this article, we will be taking a look at the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. The U.S.
Top 10 Value Stocks to Buy Under $10
In this article, we will discuss the Top 10 Value Stocks to Buy Under $10.
10 Best Large Cap Penny Stocks Under $10 to Buy Now
In this article, we will look at the 10 Best Large Cap Penny Stocks Under $10 to Buy Now.
9 Best IPO Stocks to Buy in 2026
In this article, we will discuss the 9 Best IPO Stocks to Buy in 2026.
11 Best Young Stocks to Buy and Hold for 20 Years
In this article, we will look at the 11 Best Young Stocks to Buy and Hold for 20 Years. On March 10, WilmerHale released its 2026 IPO report, highlighting an overview and outlook of the US IPO market.
Haleon (HLN) Reports 3% Organic Growth in 2025 Driven by 'Win as One' Strategy
Haleon (NYSE:HLN) is one of the most promising stocks under $20.
12 Most Promising Stocks Under $20
On March 6, Dan Niles, founder and portfolio manager at Niles Investment Management, joined CNBC's 'Power Lunch' to provide a cautious perspective on the current market rally, warning investors not to...
Hedge Fund Resource Center